Father fights to prevent daughter, diagnosed as suffering gender dysphoria, being given puberty-blocking drug Lupron

RINCE GEORGE — The British Columbia Supreme Court has stepped in to allow an 11-year-old child diagnosed with gender dysphoria to be represented in a parental dispute over medical treatment.

The child, identified only as J.K. in court documents, was born female and is transitioning to become male, a treatment that includes taking a puberty-blocking drug called Lupron.

J.K. and his mother both asked the court to appoint a litigation guardian to represent the child after J.K.’s father launched legal action to try to stop the Lupron treatment.

Court documents show J.K.’s mother has been supportive of his transition but the father argues that the treatment was undertaken without his consent and the child has not been adequately assessed by experts.